Egyesitett Szent Istvan es Szent Laszlo Korhaz, Budapest, Hungary Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT02810444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now